Internal Server Error

About Kinled Holding

Kinled Holding is a venture capital firm founded in 1980. It is primarily based out of Hong Kong, China. As of Feb 2023, Kinled Holding has invested in 89 companies. It primarily invests in Seed round in Switzerland based startups. Its investments are spread across a wide range of sectors from Life Sciences to Consumer and High Tech. Most recently it participated in the $***** Series A round of Nanoflex Robotics Overall, Kinled Holding portfolio has seen 1 unicorn, 7 IPOs and 17 acquisitions including key companies like Zopa, FullCircl and Orchestra BioMed. A lot of funds co-invest with Kinled Holding, with names like Greatbatch sharing a substantial percentage of its portfolio. Kinled Holding has team of 8 people including 3 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns

Kinled Holding's List of Top Investments

Kinled Holding has a portfolio of 89 companies, one of which is a Unicorn. Their most notable investments are in Peerbridge Health and PreComb.Their portfolio spans across United Kingdom, United States, Switzerland and 14 more locations. They have invested in Life Sciences, Consumer, High Tech and 25 other sectors, across stages such as Seed, Series A  and 2 more. Here is the list of top investments by Kinled Holding:

1. Zopa

Digital bank offering accounts, loans, credit cards, savings, finance. It offers a full suite of financial products including current accounts, personal loans, credit cards, savings accounts, and car finance. Combining the reliability of traditional banking with the convenience of an intuitive app, it helps customers manage, grow, and access their money efficiently while providing competitive rates, cashback, and seamless digital experiences.

Key facts about Zopa

  • Founded Year: 2005
  • Location: London (United Kingdom)
  • Annual Revenue: £100M - £500M as on Dec 31, 2024
  • Valuation: $*****
  • Stage: Series H
  • Total Funding till date: $968M
  • Employee Count: 1,051 as on Aug 31, 2026
  • Investors: Northzone, Benchmark and 35 Others
  • Latest Funding Round: Series H, Dec 06, 2024, $*****
  • Highlight: Editors' Pick
Cloud based customer journey management software. The platform offers software that enables members to implement business policies, and onboard business customers with automated KYC, AML, and credit checks. It provides an overview of customers, including KYC, AML, and credit information. The platform provides access to insights to connect with new prospects and markets. It allows businesses to onboard customers using automated IDV software. It caters its solution to industries such as bank, fintech, insurance, and more.

Key facts about FullCircl

  • Founded Year: 2006
  • Location: Winnersh (United Kingdom)
  • Annual Revenue: £0 - £1M as on Dec 31, 2023
  • Stage: Acquired
  • Total Funding till date: $20.8M
  • Employee Count: 63 as on May 31, 2026
  • Investors: Kreos Capital, Volution and 43 Others
  • Latest Funding Round: Series B, Jun 13, 2019, $*****
  • Highlight: Acquired
Pockit provides debit cards for consumers. It can be used for services such as money transfers, cash withdrawal, online/offline payments, and more. It provides an account to monitor expenses & building credits.

Key facts about Pockit

  • Founded Year: 2010
  • Location: London (United Kingdom)
  • Annual Revenue: £1M - £10M as on Dec 31, 2021
  • Valuation: $*****
  • Stage: Series C
  • Total Funding till date: $50M
  • Employee Count: 53 as on Aug 31, 2026
  • Investors: Alternatives Reality, Rventures and 36 Others
  • Latest Funding Round: Conventional Debt, Mar 17, 2026, $*****
  • Highlight: Editors' Pick
App-based ride-hailing aggregator. Users can book rides by providing location, user details, payment details, preferred dates, and more.

Key facts about Wheely

Developer of medical devices for hypertension and atherosclerosis treatment. The companies product portfolio includes Virtue Sirolimus-Eluting Balloon and BackBeat Cardiac Neuromodulation Therapy. Virtue Sirolimus-Eluting Balloon delivers delayed-release bioabsorbable particle encapsulated Sirolimus. This can be used for the prevention of restenosis of treated arteries.

Key facts about Orchestra BioMed

Kinled Holding's Investments by Stage

Kinled Holding has made 3 investments in Seed stage with an average round size of $2.02M, 2 investments in Series A stage with an average round size of $6.7M, 2 investments in Series B stage with an average round size of $6.76M and 1 investment in Series C stage with an average round size of $18M.
Here are Kinled Holding's investments by stage:
Stage of entry
No. of Investments
Seed
3
Series A
2
Series B
2
Series C
1
Breakdown of Kinled Holding's investments by stage of entrySeed (3)Series A (2)
Note: We have considered here, only first round of investments

Kinled Holding's Investments by Sector

Kinled Holding has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Robotics - Industry Applications and Enterprise Applications. Notably, it has invested in 65 Tech companies, 55 Enterprise (B2B) companies, 24 Consumer (B2C) companies and at least 21 companies focusing on Software.
Here are Kinled Holding's investments by sector:
Sector
No. of Investments
Life Sciences
6
High Tech
5
HealthTech
2
Robotics - Industry Applications
2
Enterprise Applications
1
Others
3
Breakdown of Kinled Holding's investments by sectorsLife Sciences (6)High Tech (5)
Note: We have considered here, only first round of investments

Kinled Holding's Investments by Geography

Kinled Holding has made most investments in Switzerland (4), followed by Canada where it has made 1 investment.
Here are Kinled Holding's investments by geography:
Country
No. of Investments
Switzerland
4
Canada
1
Spain
1
United Kingdom
1
United States
1
Breakdown of Kinled Holding's investments by countriesSwitzerland (4)Canada (1)
Note: We have considered here, only first round of investments

Kinled Holding's recent investments

Kinled Holding has not made any investment in 2026 so far.
Here are the most recent investments by Kinled Holding:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Feb 09, 2023
Switzerland
Series A
3176
Oct 04, 2022
Switzerland
Seed
1840
Apr 26, 2021
Switzerland
Seed
7974
  [+1]
Mar 04, 2020
Canada
Seed
4539
Jan 10, 2020
United Kingdom
Series A
8794

Unicorns in Kinled Holding's Portfolio

Kinled Holding has 1 unicorn in its portfolio - Zopa. The most recent unicorn in their portfolio is Zopa which became a unicorn in 2021, 5 years before Kinled Holding first invested in it.
Here is a list of unicorns in Kinled Holding's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
72
Provider of digital banking services including loans savings and accounts
2005
London
Series H
aharjzc

IPOs and Publicly Listed companies in Kinled Holding's Portfolio

7 of Kinled Holding's portfolio companies have become public. Orchestra BioMed got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jan 2023 and Distribution Finance Capital got listed on the London Stock Exchange (LSE) at marketcap of $139M.
Here are Kinled Holding's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jan 26, 2023
-
-
9976
May 09, 2019
-
-
2873
Feb 21, 2018
-
-
4660
Feb 14, 2018
-
-
8125
Sep 23, 2016
-
-
8112

Acquired companies in Kinled Holding's Portfolio

17 companies from Kinled Holding's portfolio have been acquired. The most recent acquisition was PlayStack.
Here are Kinled Holding's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
May 29, 2026
-
-
4634
Mar 17, 2026
-
-
4232
Jan 09, 2026
-
-
8319
Oct 30, 2024
-
-
8747
Apr 02, 2024
-
-
2074

Team profile of Kinled Holding

Kinled Holding has a team of 8 members including 3 Partners and 2 Principals located in United Kingdom and China. Kinled Holding's team does not sit on the board of any company as of now.
Here is a list of all team members in Kinled Holding:
Name
Designation
Location
Board Memberships
Contact Details
Partner
London
-
-
Partner
China
-
-
Partner
United Kingdom
-
-
Principal
Cobham
-
-
Principal
United Kingdom
-
-

Co-investors of Kinled Holding

Over the past 10 years, 25 investors have co-invested in Kinled Holding's portfolio companies. This includes funds and angels.

  • Invested before Kinled Holding: Venture Kick, BioMedPartners and 7 others have invested in rounds before Kinled Holding. There are 2 companies where Venture Kick has invested before Kinled Holding and 1 company where BioMedPartners has invested before Kinled Holding.
  • Top Co-investors of Kinled Holding: 11 investors entered a company along with Kinled Holding. These include investors like Greatbatch (1 company).
  • Invested after Kinled Holding: A total of 5 investors have invested in Kinled Holding's portfolio after their investments. Top Investors include CIP Merchant Capital (1 company), Graphene Ventures (1 company) and Innosuisse (1 company).

Recent News related to Kinled Holding

•
System1 processes $25mglobaluniversityventuring.com•Sep 18, 2018•System1, System1 Biosciences, CRV, Liquid 2 Ventures and 8 others
View all news related to Kinled Holding

FAQs about Kinled Holding

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford